Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-21

Development of neuroprotective leadstructures derived from neuropeptid qynad

Obiettivo

Genopia Biomedical GmbH is a European biotechnology company focused on -Drug Development and Target Discovery -Protein Interaction Screening -Rational Designed Protein BioChips We are currently offering two fellow positions/looking for two individuals (1 postgraduate, 1 postdoc) with background in protein-chemistry and hands-on experience in one or more of following techniques: 2D-electrophoresis, mass spectrometry, functional characterization of proteins, pull-down-assays and immuno- precipitation, protein biochip technologies. In close cooperation with our R&D partner institution at the University of Ulm the candidates will be involved in cutting-edge research with world leading experts in neurophysiology in area of multiple sclerosis and ion channel research. Their task will be the investigation of neuroprotective peptides: Identification of target proteins; Isolation of precursorpeptide; Screening of a peptide library; Electrophysiological testing of peptides. Genopia will offer the fellows active support during their stay and the experienced research group at the University of Ulm will provide a sound scientific basis.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Dati non disponibili

Invito a presentare proposte

Dati non disponibili

Meccanismo di finanziamento

BUR - Bursaries, grants, fellowships

Coordinatore

GENOPIA BIOMEDICAL GMBH
Contributo UE
Nessun dato
Indirizzo
Albert-Einstein-Allee 11
89069 ULM
Germania
Costo totale
Nessun dato